Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Parera, Mariona ^a   Martrus, Gloria ^a   Franco, Sandra ^a   Clotet, Bonaventura ^a   Martinez, Miguel Angel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NONSTRUCTURAL PROTEIN 4A; NS3 SERINE PROTEASE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIOPHAGE LAMBDA; CANINE HEPACIVIRUS; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; GENE EXPRESSION; GENETIC SCREENING; GENOTYPING TECHNIQUE; HEPATITIS C VIRUS; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REPRESSOR GENE; VIRUS REPLICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOVIRUSES, CANINE; ANIMALS; DOGS; HEPACIVIRUS; HUMANS; IMMUNITY, INNATE; PROTEOLYSIS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

CANIS FAMILIARIS; ENTEROBACTERIA PHAGE LAMBDA; EQUIDAE; ESCHERICHIA COLI; HEPACIVIRUS; HEPATITIS C VIRUS;

EID: 84864764820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042481     Document Type: Article

References (39)

1. Simmonds P, (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85: 3173-3188.
2. Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P, (2011) The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 92: 233-246.
3. Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, et al. (2011) Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A 108: 11608-11613.
4. Burbelo PD, Dubovi EJ, Simmonds P, Medina JL, Henriquez JA, et al. (2012) Serology enabled discovery of genetically diverse hepaciviruses in a new host. J Virol.
5. Chevaliez S, Pawlotsky JM, (2007) Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13: 2461-2466.
6. Gale M Jr, Foy EM, (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
7. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
8. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
9. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
10. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
11. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
12. Suthar MS, Gale M Jr, Owen DM, (2009) Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses. Cell Microbiol 11: 880-888.
13. Lemon SM, (2010) Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 285: 22741-22747.
14. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
15. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102: 2992-2997.
16. Patel MR, Loo YM, Horner SM, Gale M Jr, Malik HS, (2012) Convergent evolution of escape from hepaciviral antagonism in primates. PLoS Biol 10: e1001282.
17. Martinez MA, Cabana M, Parera M, Gutierrez A, Este JA, et al. (2000) A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother 44: 1132-1139.
18. Martinez MA, Clotet B, (2003) Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob Agents Chemother 47: 1760-1765.
19. Parera M, Clotet B, Martinez MA, (2004) Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease. J Virol 78: 14057-14061.
20. Franco S, Parera M, Aparicio E, Clotet B, Martinez MA, (2007) Genetic and catalytic efficiency structure of an HCV protease quasispecies. Hepatology 45: 899-910.
21. Fernandez G, Clotet B, Martinez MA, (2007) Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J Virol 81: 2485-2496.
22. Parera M, Fernandez G, Clotet B, Martinez MA, (2007) HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24: 382-387.
23. Parera M, Perez-Alvarez N, Clotet B, Martinez MA, (2009) Epistasis among deleterious mutations in the HIV-1 protease. J Mol Biol 392: 243-250.
24. Aparicio E, Franco S, Parera M, Andres C, Tural C, et al. (2011) Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients. J Virol 85: 5961-5969.
25. Ptashne M (1986) A Genetic Switch. Cambridge, MA: Cell Press.
26. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
27. Shimizu Y, Yamaji K, Masuho Y, Yokota T, Inoue H, et al. (1996) Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol 70: 127-132.
28. Liverton NJ, Holloway MK, McCauley JA, Rudd MT, Butcher JW, et al. (2008) Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease. J Am Chem Soc 130: 4607-4609.
29. Seiwert SD, Andrews SW, Jiang Y, Serebryany V, Tan H, et al. (2008) Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227). Antimicrob Agents Chemother 52: 4432-4441.
30. Gottwein JM, Scheel TK, Jensen TB, Ghanem L, Bukh J, (2011) Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses. Gastroenterology 141: 1067-1079.
31. Pawlotsky JM, (2011) Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 53: 1742-1751.
32. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr, (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
33. Urbani A, Biasiol G, Brunetti M, Volpari C, Di Marco S, et al. (1999) Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide. Biochemistry 38: 5206-5215.
34. Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, et al. (2007) GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81: 964-976.
35. Bukh J, (2011) Hepatitis C homolog in dogs with respiratory illness. Proc Natl Acad Sci U S A 108: 12563-12564.
36. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
37. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, et al. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 364-377.
38. Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, et al. (2011) Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85: 2891-2906.
39. Sauer RT, (1978) DNA sequence of the bacteriophage gama cI gene. Nature 276: 301-302.